Hospital da Cidade de Passo Fundo - HCPF

Passo Fundo, Rio Grande do Sul 99010-260

0 studies enrolling now · 3 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Neoplasms, Non-Small Cell Lung Cancer

Studies at this site

• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) — Completed
• A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC — Completed